BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30911917)

  • 1. Evaluation of chemotherapy-induced toxicity and health-related quality of life amongst early-stage breast cancer patients receiving Chinese herbal medicine in Malaysia.
    Liew AC; Peh KK; Tan BS; Zhao W; Tangiisuran B
    Support Care Cancer; 2019 Dec; 27(12):4515-4524. PubMed ID: 30911917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic adverse events of chemotherapy in breast cancer patients:Using CTCAE, PRO-CTCAE, and EORTC QLQ-C30.
    Arahori H; Kondo K; Imai Y; Bando T; Inoue H; Sasa S; Takizawa H
    J Med Invest; 2024; 71(1.2):82-91. PubMed ID: 38735729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Chinese herbal medicine for cancer palliative care: overview of systematic reviews with meta-analyses.
    Chung VC; Wu X; Hui EP; Ziea ET; Ng BF; Ho RS; Tsoi KK; Wong SY; Wu JC
    Sci Rep; 2015 Dec; 5():18111. PubMed ID: 26669761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prayer-for-health and complementary alternative medicine use among Malaysian breast cancer patients during chemotherapy.
    Chui PL; Abdullah KL; Wong LP; Taib NA
    BMC Complement Altern Med; 2014 Oct; 14():425. PubMed ID: 25358688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical study on postoperative triple-negative breast cancer with Chinese medicine: Study protocol for an observational cohort trial.
    Chen J; Qin Y; Sun C; Hao W; Zhang S; Wang Y; Chen J; Chen L; Ruan Y; Liu S
    Medicine (Baltimore); 2018 Jun; 97(25):e11061. PubMed ID: 29923998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality-of-life outcomes: a reflexology trial with patients with advanced-stage breast cancer.
    Wyatt G; Sikorskii A; Rahbar MH; Victorson D; You M
    Oncol Nurs Forum; 2012 Nov; 39(6):568-77. PubMed ID: 23107851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Perioperative Docetaxel-induced Limb Edema on Health-related Quality of Life in Patients with Early-stage Breast Cancer: A Prospective Observational Study.
    Matsumoto K; Morimoto Y; Wakatsuki J; Sakuma D; Mukouyama K; Inoue M; Kimura A; Hirosawa I; Watanabe K
    Yakugaku Zasshi; 2024; 144(6):685-690. PubMed ID: 38825477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Symptom Severity and Quality of Life among Patients with Cancer Using Conventional Therapies with/without Herbal Medicines in Uganda: A Cross-Sectional Study.
    Asiimwe JB; Nagendrappa PB; Jatho A; Kamatenesi MM; Atukunda EC
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3195-3205. PubMed ID: 37774072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese Herbal Medicines as an Adjunctive Therapy for Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.
    Li B; Gan R; Yang Q; Huang J; Chen P; Wan L; Guo C
    Evid Based Complement Alternat Med; 2015; 2015():350730. PubMed ID: 26681966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer - An Overview.
    Tarasiuk A; Mirocha G; Fichna J
    Curr Treat Options Oncol; 2023 Dec; 24(12):1852-1869. PubMed ID: 38079061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nurse-led group information for patients with breast cancer: Equal to individual information? A comparative study.
    Dieperink KB; Ellegaard E; Astrup AL; Hasse HT; Elnegaard CM; Jensen JD
    Nurs Open; 2021 Jan; 8(1):423-433. PubMed ID: 33318850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy.
    Liao GS; Apaya MK; Shyur LF
    Evid Based Complement Alternat Med; 2013; 2013():437948. PubMed ID: 23840256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial.
    Jacot W; Arnaud A; Jarlier M; Lefeuvre-Plesse C; Dalivoust P; Senesse P; Azzedine A; Tredan O; Sadot-Lebouvier S; Mas S; Carayol M; Bleuse JP; Gourgou S; Janiszewski C; Launay S; D'Hondt V; Lauridant G; Grenier J; Romieu G; Ninot G; Vanlemmens L
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33050321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Combined Treatment with Traditional Chinese Medicine and Western Medicine on the Prognosis of Patients with Breast Cancer.
    Lee YC; Chen YH; Huang YC; Lee YF; Tsai MY
    J Altern Complement Med; 2020 Sep; 26(9):833-840. PubMed ID: 32924556
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of Jianpishengsui for chemotherapy-related fatigue in patients with non-small cell lung cancer: study protocol for a randomized placebo-controlled clinical trial.
    Xiao Z; Hu L; Lin J; Lu L; Huang X; Zhu X; Teo C; Lin L
    Trials; 2020 Jan; 21(1):94. PubMed ID: 31948475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase II Randomized Controlled Trial of Renshen Yangrong Tang Herbal Extract Granules for Fatigue Reduction in Cancer Survivors.
    Xu Y; Wang XS; Chen Y; Shi Q; Chen TH; Li P
    J Pain Symptom Manage; 2020 May; 59(5):966-973. PubMed ID: 31668965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Chinese Herbal Medicine as a Complementary Treatment for Neutropenia Prevention and Immunity Modulation During Chemotherapy in Patients With Breast Cancer: Protocol for a Real-World Pragmatic Clinical Trial.
    Wang KH; Shen HS; Chu SC; Wang TF; Lin CW; Huang WH; Wu YF; Ho CC; Pang CY; Li CC
    JMIR Res Protoc; 2024 Mar; 13():e55662. PubMed ID: 38466979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scoparone inhibits breast cancer cell viability through the NF‑κB signaling pathway.
    Wu X; Li X; Li J; Zhao X; Cui Y; Eerdun C
    Exp Ther Med; 2023 Jul; 26(1):328. PubMed ID: 37346408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse Probability of Treatment Weighting in 5-Year Quality-of-Life Comparison among Three Surgical Procedures for Hepatocellular Carcinoma.
    Chang DM; Chen YF; Chen HY; Chiu CC; Lee KT; Wang JJ; Sun DP; Lee HH; Shiu YT; Chen IT; Shi HY
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612245
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.